Conformational Behavior of Human α-Synuclein is Modulated by Familial Parkinson’s Disease Point Mutations A30P and A53T
Tóm tắt
Từ khóa
Tài liệu tham khảo
Altschuler, 1999, Aluminum-containing antacids as a cause of idiopathic Parkinson’s disease, Med. Hypotheses, 53, 22, 10.1054/mehy.1997.0701
Clayton, 1998, The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, Trends Neurosci., 21, 249, 10.1016/S0166-2236(97)01213-7
Clark, 1981, Infrared and laser-Raman spectroscopic studies of thermally-induced globular protein gels, Int. J. Pept. Prot. Res., 17, 353, 10.1111/j.1399-3011.1981.tb02002.x
Cohlberg J.A, Li J, Uversky VN, Fink AL. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro. Biochemistry 2001;40.
Conway, 1998, Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease, Nat. Med., 4, 1318, 10.1038/3311
Conway, 2000, Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson’s disease are typical amyloid, Biochemistry, 39, 2552, 10.1021/bi991447r
Conway, 2000, Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapy, Proc. Natl. Acad. Sci. U.S.A., 97, 571, 10.1073/pnas.97.2.571
Crowther, 1998, Synthetic filaments assembled from C-terminally truncated alpha-synuclein, FEBS Lett., 436, 309, 10.1016/S0014-5793(98)01146-6
Duvoisin, 1992, A brief history of Parkinsonism, Neurol. Clin., 10, 310, 10.1016/S0733-8619(18)30211-1
El-Agnaf, 1998, Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson’s disease, FEBS Lett., 440, 67, 10.1016/S0014-5793(98)01419-7
Fink, 1998, Protein aggregation: folding aggregates, inclusion bodies and amyloid, Fold Design, 3, 9, 10.1016/S1359-0278(98)00002-9
Forno, 1996, Neuropathology of Parkinson’s disease, J. Neuropathol. Exp. Neurol., 55, 259, 10.1097/00005072-199603000-00001
George, 1995, Characterization of a novel protein regulated during the critical period for song learning in the zebra finch, Neuron, 15, 361, 10.1016/0896-6273(95)90040-3
Giasson, 1999, Mutant and wild-type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro, J. Biol. Chem., 274, 7619, 10.1074/jbc.274.12.7619
Glatter O, Kratky O. Small angle X-ray scattering. New York: Academic Press, 1982.
Goedert, 1997, Familial Parkinson’s disease: the awakening of alpha-synuclein, Nature (Lond.), 388, 232, 10.1038/40767
Good, 1992, Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson’s disease: a LAMMA study, Brain Res., 593, 343, 10.1016/0006-8993(92)91334-B
Gorell, 1999, Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson’s disease, Neurotoxicology, 20, 239
Gourie-Devi, 1991, Treatment of Parkinson’s disease in ‘Ayurveda’ (ancient Indian system of medicine): discussion paper, J. R. Soc. Med., 84, 491, 10.1177/014107689108400814
Hertzman, 1994, A case-control study of Parkinson’s disease in a horticultural region of British Columbia, Mov. Disord., 9, 69, 10.1002/mds.870090111
Hirsch, 1991, Iron and aluminum increase in the substantia nigra of patients with Parkinson’s disease: an X-ray microanalysis, J. Neurochem., 56, 446, 10.1111/j.1471-4159.1991.tb08170.x
Hsu, 1998, Expression pattern of synucleins (non-Abeta component of Alzheimer’s disease amyloid precursor protein/alpha-synuclein) during murine brain development, J. Neurochem., 71, 338, 10.1046/j.1471-4159.1998.71010338.x
Ismail, 1992, Aggregation of chymotrypsinogen: portrait by infrared spectroscopy, Biochim. Biophys. Acta, 1121, 183, 10.1016/0167-4838(92)90353-F
Iwai, 1995, The precursor protein of non-A beta component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system, Neuron, 14, 467, 10.1016/0896-6273(95)90302-X
Jakes, 1994, Identification of two distinct synucleins from human brain, FBS Lett., 345, 27, 10.1016/0014-5793(94)00395-5
Kendrick, 1998, Aggregation of recombinant human interferon gamma: kinetics and structural transitions, J. Pharm. Sci., 87, 1069, 10.1021/js9801384
Krüger, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease, Nat. Genet., 18, 106, 10.1038/ng0298-106
Le Couteur, 1999, Pesticides and Parkinson’s disease, Biomed. Pharmacother., 53, 122, 10.1016/S0753-3322(99)80077-8
Lewy FH. Paralysis Agitans. Pathologische Anatomie. In: Lewandowski M, editor. Handbuch der Neurologie. Berlin: Springer, 1912. p. 920–33.
Li, 2001, Effect of familial Parkinson’s disease point mutations A30P and A53T on structural properties, “stability”, aggregation and fibrillation capability of human α-synuclein, Biochemistry, 40, 11604, 10.1021/bi010616g
Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The herbicide paraquate causes upregulation and aggregation of α-synuclein in mice. J Biol Chem 2001;276.
Masliah, 2000, Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders, Science, 287, 1265, 10.1126/science.287.5456.1265
Maroteaux, 1988, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci., 8, 2804, 10.1523/JNEUROSCI.08-08-02804.1988
Naiki, 1989, Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, Thioflavin T1x, Anal. Biochem., 177, 244, 10.1016/0003-2697(89)90046-8
Naiki, 1990, Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T, Lab. Invest., 62, 768
Narhi, 1999, Both familial Parkinson’s disease mutations accelerate alpha-synuclein aggregation, J. Biol. Chem., 274, 9843, 10.1074/jbc.274.14.9843
Nielsen, 2001, Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism, Biochemistry, 40, 6036, 10.1021/bi002555c
Nielsen, 2001, Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy, J. Pharm. Sci., 90, 29, 10.1002/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4
Oberg, 1998, A new attenuated total reflectance Fourier transform infrared spectroscopy method for the study of proteins in solution, Anal. Biochem., 256, 92, 10.1006/abio.1997.2486
Oberg, 1994, Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR, Biochemistry, 33, 2628, 10.1021/bi00175a035
Okazaki, 1961, J. Nerophathol. Exp. Neurol., 21, 442
Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease, Science, 276, 2045, 10.1126/science.276.5321.2045
Przybycien, 1994, Secondary structure characterization of beta-lactamase inclusion bodies, Protein Eng., 7, 131, 10.1093/protein/7.1.131
Serpell, 2000, Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation, Proc. Natl. Acad. Sci. U.S.A., 97, 4897, 10.1073/pnas.97.9.4897
Spillantini, 1998, Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies, Proc. Natl. Acad. Sci. U.S.A., 95, 6469, 10.1073/pnas.95.11.6469
Tanner, 1989, The role of environmental toxins in the etiology of Parkinson’s disease, Trends Neurosci., 2, 49, 10.1016/0166-2236(89)90135-5
Trojanowski, 1998, Fatal attractions: abnormal protein aggregation and neuron death in Parkinson’s disease and Lewy body dementia, Cell Death Diff., 5, 832, 10.1038/sj.cdd.4400432
Tsuruta, 1998, A wide-bandpass multilayer monochromator for biological small-angle scattering and fiber diffraction studies, J. Appl. Cryst., 31, 672, 10.1107/S0021889898002702
Uversky, 1998, Association-induced folding in globular proteins, Proc. Natl. Acad. Sci. U.S.A., 95, 5480, 10.1073/pnas.95.10.5480
Uversky, 1999, Association of partially-folded intermediates of Staphylococcal nuclease induces structure and stability, Protein Sci., 8, 161, 10.1110/ps.8.1.161
Uversky, 2000, Why are “natively unfolded” proteins unstructured under the physiological conditions?, Proteins Struct. Funct. Genet., 42, 327
Uversky, 2001, Evidence for a partially-folded intermediate in α-synuclein fibrillation, J. Biol. Chem., 676, 10737, 10.1074/jbc.M010907200
Uversky, 2001, Pesticides directly accelerate the rate of α-synuclein fibril formation: a possible factor in Parkinson’s disease, FEBS Lett., 500, 105, 10.1016/S0014-5793(01)02597-2
Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation and fibril formation of human α-synuclein: a possible molecular link between Parkinson’s disease and heavy metal exposure. J Biol Chem 2001c;276, in press.
Uversky VN, Lee H-J, Li J, Fink AL, Lee S-J. Stabilization of partially-folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations. J Biol Chem 2001d;276, in press.
Wakatsuki, 1992, Small-angle-X-ray-scattering diffraction system for studies of biological and other materials at the Stanford-Synchrotron-Radiation-Laboratory, Rev. Sci. Instrum., 63, 1736, 10.1063/1.1143332
Weinreb, 1996, NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded, Biochemistry, 35, 13709, 10.1021/bi961799n
Wood, 1999, Alpha-synuclein fibrillogenesis is nucleation-dependent: implications for the pathogenesis of Parkinson’s disease, J. Biol. Chem., 274, 19509, 10.1074/jbc.274.28.19509
Yasui, 1992, Calcium, magnesium and aluminum concentrations in Parkinson’s disease, Neurotoxicology, 13, 593